Patient Accessibility

Utilizing our single-use NeuroCap and portable NeuroEEGenables clinicians to conduct an EEG test anywhere. Whether visiting a hospital, emergency room, ICU, specialty clinic, ambulance, or even on the athletic field our products are designed to be used anywhere. Ask for Brain Scientific by name to receive rapid EEG testing.


Clinician Efficiency

NeuroCap and NeuroEEG were designed to make testing more efficient allowing clinicians time to focus on test readings rather than focus on the labor-intensive application process of current electrode placement technology. Ease of prep and rapid testing enables clinicians to complete more EEG tests throughout the day, facilitating their ability to diagnose more patients with ease and efficiency.


Diagnose Confidently

Brain Scientific’s Neurology EEG Ecosystem provides clinicians and patients confidence in gaining rapid access to accurate EEG test results. Beginning with the ease of use and application of NeuroCap when diagnosing neurological conditions such as epilepsy and numerous seizure disorders, brain tumors, infections, injury, dementia, stroke to attention disorders.


Pre-gelled EEG cap, Fast Prep and Testing, Simple to Use

At Brain Scientific, our mission is to provide clinicians with the right solution at the right time; wherever, whenever a diagnosis is needed.

Our priority is to enable rapid, convenient, and accurate neurology solutions.

Accessible | Efficient | Accurate

Conventional EEG practices in Neurology have been static for years compounding frustrations for clinicians and patients across the board.

Until now. 


Our innovative NeuroCap, NeuroEEG and  NeuroHub™ (coming in 2023) lead the way in advancements for prepping, testing, and interpreting EEG studies anytime, anywhere.




Disposable EEG headset with 22 pre-gelled electrodes, and 19 active channels in accordance with the international 10-20 system




Portable, wireless amplifier to use in conjunction with our NeuroCap





State-of-art Neurology SaaS platform coming 2023 by the Brain Scientific team to collect and aggregate data from current and future BRSF devices like the NeuroCap™, NeuroEEG™

NeuroCap™+ NeuroEEG™+ NeuroHub™

The team at Brain Scientific has made it our mission to build a complete Neurology EEG EcoSystem, offering two distinct devices to streamline your EEG prep, testing, and diagnosis. NeuroCap™ our disposable headset with 22 pre-gelled electrodes follows the international 10–20 system, and our hand-held, wireless, NeuroEEG™ amplifier provides confidence to clinicians and patients when testing to detect abnormalities in brain waves, or in the electrical activity of the brain to diagnose neurological disorders. 


NeuroCap™ provides numerous benefits to clinicians and patients. Any healthcare worker can prep and apply NeuroCap™ in just 5-minutes, no longer requiring you to wait for your tech-on-call, all the while shortening the time to reading test results, evaluating, and diagnosing your patient. NeuroCap™ is compatible with 3rd party amplifiers when using our universal cable with the touch-proof DIN connectors.  


As our healthcare providers focus on enabling and utilizing telehealth to diagnose and treat patients, NeuroCap™ enables tele-neurology allowing clinicians to make rapid decisions remotely and bridging the gap in access to neurological care. Using NeuroCap™ can accelerate the time to diagnosis, eliminate the need for your patients to travel distances to testing site facilities, and provide a timely and accurate diagnosis in an efficient manner. 


NeuroEEG™ is our amplifier that provides clinicians the same quality as traditional EEG equipment. The portability and wireless connectivity offer you the ability to test anywhere in your hospital, office, remote setting, or ambulance to quickly serve your patients. 


NeuroHub™ is a state-of-art Neurology SaaS platform used to collect and aggregate data from current and future BRSF devices like the NeuroCap™, NeuroEEG™, and external sources such as research and medical data banks, 3rd-party devices, and clinical-use applications. NeuroHub™ will allow comprehensive monitoring and facilitate collaborative diagnosis, analysis, research, treatment, and prevention by employing sophisticated Artificial Intelligence (AI) and machine learning (ML) algorithms utilizing historical and current patient, device, and platform data.


Brainbox Validates NeuroCap In Testing Regimen; Adds Them to its Sports Medicine and Pharma Solutions

February 6, 2023

Brainbox, a leading Contract Research Organization (CRO) with decades of technical and academic expertise, finds Brain Scientific’s NeuroCap perfect for its applications.

Children’s Hospitals Are Increasingly Using the NeuroCap™ to Monitor Pediatric Patients

February 2, 2023

Brain Scientific Continues to See Rapid Adoption of NeuroCap in Key Markets: Ones That Make a Difference, Like Ensuring Children Get Time-Sensitive Care for Threatening Conditions

Brain Scientific Partners with SysteMedic, Receives First Purchase Order for NeuroCaps in Israel

January 24, 2023

International Markets Show Immediate and Increasing Demand for FDA-Cleared, CE Mark-Approved NeuroCap Device

Brain Scientific Signs Agreement with MVAP Medical Supplies to Go After Rapidly Growing Pediatric Neurodiagnostic Space

December 15, 2022

MVAP Medical Supplies’ Industry-Leading EEG Catalog and Distribution Network Continue Brain Scientific’s Push Forward with Its Easy-to-Use, Quick-to-Set-Up and Comfortable NeuroCap™ – a Winning Combination for Pediatric Patient Care

Brain Scientific Inks Deal with Fulcrum to Go After At-Home Diagnostic Space, Hires VP of Marketing and Communications

December 1, 2022

Fulcrum leverages their experience and network of at-home diagnostic service providers, and Kevin Winterfield joins as vice president of marketing and communications to accelerate brand awareness and sales

Brain Scientific Announces Release of Improved NeuroCap(TM) and New US Distribution Deal with D&D Medical

November 15, 2022

Company Continues to Build Momentum as It Launches Its Disruptive Technologies in the Marketplace

Daniel Cloutier, a Veteran Sales Executive, Joins Brain Scientific as Chief Revenue Officer

November 1, 2022

Company Continues to Build Momentum as It Launches Its Disruptive Technologies in the Marketplace

Brain Scientific Announces CE Mark Approval for NeuroCap™ Device

August 24, 2022

The CE mark confirms that Brain Scientific meets all European Medical Device Directive requirements to begin commercializing its innovative neurological devices across the European Continent and other CE mark geographies.


Brain Scientific Announces Private Placement of $5.6 Million of Senior Secured Convertible Debentures and Warrants, Converts Approximately $12.9 Million of Existing Debt into Equity

June 15, 2022

Brain Scientific (OTCQB: BRSF) (the “Company”), a medical technology company with multiple patents and FDA-cleared products, today announces that it has entered into definitive agreements with certain institutional and accredited investors for the sale of senior secured convertible debentures and warrants to purchase shares of the Company’s common stock, resulting in total gross proceeds of approximately $5.1 million before deducting the placement agent’s fees and other offering expenses.


Expedited EEG testing for Epilepsy

June 7, 2022

According to the World Health Organization, each year five-million people worldwide are diagnosed with Epilepsy, a neurological disorder that affects the brain. While there is no cure for epilepsy, early detection and treatment of seizures is critical for patient care. The WHO estimates up to 70% of people with epilepsy could live seizure-free if properly…

Your questions are important to us.

Have a question? Contact Brain Scientific and a member of our team will reach back out to you.